Skip to content

Technology
Clinical Data
Pipeline
About
Team
Events & Media
Contact

Category: Press

Colin Story - BetaGlue

News Press

27/02/2023

BetaGlue® renews the BoD: Dr Colin Story appointed CEO

Technology
Clinical Data
Pipeline
Team
Contact

Legal headquarters: Via della Moscova, 3 – 20121 Milan, Italy

YntraDose® is currently under development and is not approved for human use or sale.

© 2025 BetaGlue Therapeutics SpA. All rights reserved | TAX ID number: 06496571214

Privacy Policy
Cookie Policy
Corporate Governance